Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 17/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29656857 | 1.00 | MGLL (0.46) | MGLLFAAHABHD6 | |
| SCHEMBL24433530 | 1.00 | MGLL (0.46) | MGLLFAAHABHD6 | |
| SCHEMBL30754166 | 1.00 | MGLL (0.46) | MGLLFAAHABHD6 | |
| SCHEMBL24433408 | 1.00 | MGLL (0.46) | MGLLFAAHABHD6 | |
| SCHEMBL29657007 | 1.00 | MGLL (0.46) | MGLLFAAHABHD6 | |
| SCHEMBL24433494 | 0.88 | MGLL (0.47) | MGLLABHD6 | |
| SCHEMBL29656730 | 0.88 | MGLL (0.47) | MGLLABHD6 | |
| SCHEMBL29911426 | 0.88 | MGLL (0.47) | MGLLABHD6 | |
| SCHEMBL29657049 | 0.88 | MGLL (0.47) | MGLLABHD6 | |
| SCHEMBL24433524 | 0.85 | MGLL (0.45) | MGLLFAAHABHD6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018120-A1 | MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2024-01-18 | — | — | US | disclosed |
| US-20240018120-A1 | MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2024-01-18 | — | — | US | disclosed |
| WO-2022101412-A1 | A MAGL INHIBITOR | H. LUNDBECK A/S (DK) | 2022-05-19 | — | — | WO | disclosed |
| US-20220153721-A1 | MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018120-A1 | MAGL INHIBITORS | MAG, MAGI3, MAGT1 | MGLL 5/4885FAAH 130/4885ABHD6 91/4885 |
| US-20220153721-A1 | MAGL INHIBITORS | MAG, MAGI3, MAGT1 | MGLL 5/4885FAAH 130/4885ABHD6 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.